Minoxidil Sulfate
SIGMA/M7920
Synonym: U-58838
CAS Number: 83701-22-8
Empirical Formula (Hill Notation): C9H15N5O4S
Molecular Weight: 289.31
MDL Number: MFCD06248907
Linear Formula: C9H15N5O4S
Product Type: Chemical
| form | powder |
| InChI | 1S/C9H15N5O4S/c10-7-6-8(1 |
| InChI key | OEOLOEUAGSPDLT-UHFFFAOYSA |
| originator | Johnson & Johnson |
| Quality Level | 200 ![]() |
| SMILES string | Nc1cc(nc(N)[n+]1OS([O-])( |
| storage temp. | −20°C |
| Application: | Minoxidil sulfate (MXS) has been used as a drug agent to study its effects on alopecia in corticotropin-releasing factor over-expressing (CRF-OE) mice. It has also been used as a positive control in an assay for the culturing of rat vibrissa follicles. |
| Biochem/physiol Actions: | Minoxidil sulfate (MXS) is an endogenous derivative of minoxidil. It possesses greater aqueous solubility and is a potent vasodilator. MXS has the potential to treat androgenic alopecia or male baldness. |
| Features and Benefits: | This compound was developed by Johnson & Johnson . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Other Notes: | Active metabolite of minoxidil. |
| Packaging: | 1 mg in glass insert |
| Packaging: | 5 mg in glass bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 - H315 - H319 - H335 |
| Precautionary statements | P301 + P312 + P330 - P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xn |
| Risk Statements | 22-36/37/38 |
| Safety Statements | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Storage Temp. | −20°C |
| UNSPSC | 12352107 |


